Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.
about
Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patientsHER-2 gene amplification can be acquired as breast cancer progressesCirculating tumor cells: approaches to isolation and characterizationBone marrow micrometastases and circulating tumor cells: current aspects and future perspectives.Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cellsCirculating tumor cells in germ cell tumors: are those biomarkers of real prognostic value? A reviewEvaluation and consequences of heterogeneity in the circulating tumor cell compartmentClinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch SystemEmerging technologies for CTC detection based on depletion of normal cellsSensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection.Isolation of rare tumor cells from blood cells with buoyant immuno-microbubblesBlood-based Tumor Markers in Lung CancerNanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urineA simple biological imaging system for detecting viable human circulating tumor cells.Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control studyIsolation of circulating tumor cells using a microvortex-generating herringbone-chip.Data-Driven Discovery of Extravasation Pathway in Circulating Tumor Cells.A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors.Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis.Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodiesConfocal images of circulating tumor cells obtained using a methodology and technology that removes normal cellsExclusive and adjuvant radiotherapy in breast cancer patients with synchronous metastases.Circulating tumor cells predict survival in early average-to-high risk breast cancer patients.Microchip-based immunomagnetic detection of circulating tumor cells.uPAR and HER2 Genes Are Usually Co-Amplified in Individual Breast Cancer Cells from Blood and Tissues.Immunomagnetic nanoscreening of circulating tumor cells with a motion controlled microfluidic system.Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancerDetection of carcinoembryonic antigen messenger RNA in blood using quantitative real-time reverse transcriptase-polymerase chain reaction to predict recurrence of gastric adenocarcinomaBreast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion.Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancerSELEX aptamer used as a probe to detect circulating tumor cells in peripheral blood of pancreatic cancer patients.Prognostic Relevance of Circulating Tumor Cells in Molecular Subtypes of Breast Cancer.Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.Recent translational research: circulating tumor cells in breast cancer patientsA novel platform for detection of CK+ and CK- CTCs.uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues.Highly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patients.Influence of surgical manipulation and surgical modality on the molecular detection of circulating tumor cells from colorectal cancerDetection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial
P2860
Q21284707-C9AD4A69-51ED-4CA3-9786-1A4BA1F755A3Q24563115-FFCA2B8E-B6E3-42B0-8665-F990405858CEQ24631347-C27B24C8-C178-4A9E-A66D-9EFC4F6470F5Q24796185-76E495AA-8555-4EE2-B45D-0947068E7580Q26748850-4061F4CF-0657-46F8-BEAC-D8375BFB5BBAQ26752116-9BB030B6-71C7-431A-AB63-962F204D0EC4Q26765357-4FA9A259-9073-458C-9299-0136498A65DBQ27004790-FEA0EA3F-4158-4943-BA1C-D5347D83F125Q27009519-2FE4C4AF-623B-4F84-ADBB-55CE781C8EA2Q27320919-B6B39CF9-5C25-4D1D-9E5C-EE0260A0EDE2Q27335994-70FDDFFB-9887-46D4-B51B-4BDDE49830BBQ28072736-F6D77267-214D-411A-8F43-B8B5704C3057Q30354652-D55DEBD8-8768-4104-A096-18B73652E24EQ30479606-F86CA8E0-934B-4850-A4ED-C96D8D2CA593Q30490534-EE7C3853-A1B3-4D23-AC1A-61289E2AF161Q30496841-AB08146C-66CB-407F-9F99-E1171EF76139Q30497257-84A2696A-E3B7-4A18-B5A3-7B4757A3A83FQ31171102-B722CC13-2693-49BF-A83C-9B45F34F04D5Q33404541-07E0AA70-5778-4434-9596-42B825E34C37Q33559128-B1147B82-739F-431D-B8E2-FA931FA2975CQ33567376-E78475B7-5F99-4986-B317-678F09D2663DQ33691179-18FDBDC1-C28B-4EDA-B63B-C78D89A552DAQ33749014-255F5173-DE6B-489B-88D9-8D2B035734CAQ33958981-0AE116BD-CC31-4D1A-A94C-DA92FE9B7F9BQ34001559-111A6017-43B1-4354-B202-2282477CCBAEQ34095775-A7932742-F481-4033-A623-10BC62051678Q34308871-5591521D-29B5-45D4-9E38-25147F3CE74DQ34334315-073BD1A4-2644-4CB3-980B-F2701386AEF5Q34341338-5A20247D-C00E-4872-AD59-5C3A8D3B9E0AQ34684041-15C458D7-294A-415B-A7F4-FE6AA9E3D8A1Q35120911-EE81B246-A795-482E-921A-C25BEF7AF53CQ35208647-405F2894-A4BB-4D3B-904D-8C9D840A3EB0Q35427994-50404452-7975-4144-A2C7-53D4E2CBDF3AQ35558093-B5B1AFA7-8CA6-4D49-BF0F-90029DAAE890Q35605832-7EC2D5C7-ABA0-41C4-8613-C4206DF4F29BQ35612329-F5F6B34A-2FF4-443A-9214-35F86522FAA9Q35720929-0D1FF2A6-80C0-4441-86F5-03AB176218BFQ35735913-4D9384DE-0773-44F3-AA07-FD40A04A6B88Q36028081-1C95CED9-3961-487D-BC58-A4103D8BF9D3Q36069885-B6E42765-E6BF-4E10-8BB1-3CB10595AD09
P2860
Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cytogenetic evidence that circ ...... with carcinoma are malignant.
@ast
Cytogenetic evidence that circ ...... with carcinoma are malignant.
@en
Cytogenetic evidence that circ ...... with carcinoma are malignant.
@nl
type
label
Cytogenetic evidence that circ ...... with carcinoma are malignant.
@ast
Cytogenetic evidence that circ ...... with carcinoma are malignant.
@en
Cytogenetic evidence that circ ...... with carcinoma are malignant.
@nl
prefLabel
Cytogenetic evidence that circ ...... with carcinoma are malignant.
@ast
Cytogenetic evidence that circ ...... with carcinoma are malignant.
@en
Cytogenetic evidence that circ ...... with carcinoma are malignant.
@nl
P2093
P1476
Cytogenetic evidence that circ ...... s with carcinoma are malignant
@en
P2093
Arthur Sagalowsky
B Michael Ghadimi
Chandra Rao
David Euhus
Edward Clifford
Hossein Saboorian
Jonathan Uhr
Kerstin Heselmeyer-Haddad
Larry Morrison
Nancy Lane
P304
P407
P50
P577
2002-07-01T00:00:00Z